This inventor holds 1 USPTO granted patent. Top assignee: Vetoquinol S.a.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Yves R Jacques: Innovator in Therapeutic Compositions
Introduction
Yves R Jacques is a notable inventor based in Annecy, France. He has made significant contributions to the field of therapeutic and hygienic compositions. His innovative work focuses on formulations intended for application to mucous membranes.
Latest Patents
Yves R Jacques holds a patent for a "Solid mucoadhesive therapeutic or hygienic composition." This composition is designed for both human and veterinary use and is administered through the buccal or nasal mucous membrane. The formulation includes a mixture of 15 to 25% by weight of a cellulosic ether that is gelifiable in the presence of an aqueous liquid, 10 to 15% by weight of a homopolymer or copolymer of acrylic acid or a physiologically acceptable salt thereof, and 30 to 45% by weight of gelatin. Additionally, it contains one or more therapeutic or hygienic active constituents. The preferred cellulosic ether is a C1-C4 alkyl ether of cellulose, a C1-C4 hydroxyalkyl ether of cellulose, or mixtures thereof.
Career Highlights
Yves R Jacques is associated with Vetoquinol S.A., a company that specializes in veterinary pharmaceuticals. His work at Vetoquinol has allowed him to focus on developing innovative solutions for therapeutic applications.
Collaborations
Throughout his career, Yves has collaborated with notable colleagues, including Bernard Boisrame and Vassilios Kaltsaltos. These collaborations have contributed to the advancement of his research and the development of effective therapeutic compositions.
Conclusion
Yves R Jacques is a distinguished inventor whose work in solid mucoadhesive therapeutic compositions has the potential to impact both human and veterinary medicine. His innovative approach and collaborations highlight his commitment to advancing therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile